Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2016

14.09.2016 | Epidemiology

Ten-year survival in women with primary stage IV breast cancer

verfasst von: Lee Guek Eng, Shaheenah Dawood, Victoria Sopik, Benjamin Haaland, Pui San Tan, Nirmala Bhoo-Pathy, Ellen Warner, Javaid Iqbal, Steven A. Narod, Rebecca Dent

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate breast cancer-specific survival at 10 years in patients who present with primary stage IV breast cancer, and to determine whether survival varies with age of diagnosis.

Methods

We retrieved the records of 25,323 women diagnosed with primary stage IV breast cancer in the surveillance, epidemiology, and end results 18 registries database from 1990 to 2012. For each case, we extracted information on age at diagnosis, tumour size, nodal status, oestrogen receptor status, progesterone receptor status, ethnicity, cause of death and date of death. The Cox proportional hazards model was used to estimate the unadjusted and adjusted hazard ratio (HR) of death due to stage IV breast cancer, according to age group.

Results

Among 25,323 women with stage IV breast cancer, 2542 (10.0 %) were diagnosed at age 40 or below, 5562 (22.0 %) were diagnosed between ages 41 and 50 and 17,219 (68.0 %) were diagnosed between ages 51 and 70. After a mean follow-up of 2.2 years, 16,387 (64.7 %) women died of breast cancer (median survival 2.3 years). The ten-year actuarial breast cancer-specific survival rate was 15.7 % for women ages 40 and below, 14.9 % for women ages 41–50 and 11.7 % for women ages 51 to 70 (p < 0.0001). In an adjusted analysis, the risk of death from breast cancer at 10 years was significantly lower for women ages 40 and below (HR 0.78; 95 % CI 0.74–0.82; p < 0.0001) and for women ages 41–50 (HR 0.82; 95 % CI 0.79–0.85; p < 0.0001), compared to women ages 51–70.

Conclusions

Approximately 13 % of women with primary stage IV breast cancer survive 10 years after diagnosis. Women diagnosed with stage IV breast cancer before age 50 have better survival at 10 years compared to older women.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (1975) SEER Cancer Statistics Review, 1975–2012. National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (1975) SEER Cancer Statistics Review, 1975–2012. National Cancer Institute, Bethesda. http://​seer.​cancer.​gov/​csr/​1975_​2012/​, based on November 2014 SEER data submission, posted to the SEER web site, April 2015
2.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York
3.
Zurück zum Zitat Colleoni M, Rotmensz N, Robertson C et al (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13(2):273–279CrossRefPubMed Colleoni M, Rotmensz N, Robertson C et al (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13(2):273–279CrossRefPubMed
4.
Zurück zum Zitat Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78(8):1838–1843CrossRefPubMed Winchester DP, Osteen RT, Menck HR (1996) The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78(8):1838–1843CrossRefPubMed
5.
Zurück zum Zitat Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315(9):559–563CrossRefPubMed Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315(9):559–563CrossRefPubMed
6.
Zurück zum Zitat Albain KS, Allred DC, Clark GM (1994) Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst 16:35–42 Albain KS, Allred DC, Clark GM (1994) Breast cancer outcome and predictors of outcome: are there age differentials? J Natl Cancer Inst 16:35–42
7.
Zurück zum Zitat Han W, Kim SW, Park IA et al (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82CrossRefPubMedPubMedCentral Han W, Kim SW, Park IA et al (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Agrup M, Stal O, Olsen K, Wingren S (2000) CerB-2 overexpression and survival in early onset breast cancer. Breast Cancer Res Treat 63(1):23–29CrossRefPubMed Agrup M, Stal O, Olsen K, Wingren S (2000) CerB-2 overexpression and survival in early onset breast cancer. Breast Cancer Res Treat 63(1):23–29CrossRefPubMed
9.
Zurück zum Zitat Dawood S, Broglio K, Ensory J, Hortobagyi GN, Giordano SH (2010) Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 21:2169–2174CrossRefPubMedPubMedCentral Dawood S, Broglio K, Ensory J, Hortobagyi GN, Giordano SH (2010) Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 21:2169–2174CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Liu J, Deng H, Jia W et al (2012) Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment. J Cancer Res Clin Oncol 138(5):837–842CrossRefPubMed Liu J, Deng H, Jia W et al (2012) Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment. J Cancer Res Clin Oncol 138(5):837–842CrossRefPubMed
11.
Zurück zum Zitat Narod SA, Giannakeas V, Iqbal J, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of DCIS. JAMA Oncol 1(7):888–896CrossRefPubMed Narod SA, Giannakeas V, Iqbal J, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of DCIS. JAMA Oncol 1(7):888–896CrossRefPubMed
12.
Zurück zum Zitat Nixon AJ, Neuberg D, Hayes DF et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12(5):888–894PubMed Nixon AJ, Neuberg D, Hayes DF et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12(5):888–894PubMed
13.
Zurück zum Zitat Iqbal J, Ginsburg O, Rochon P, Sun P, Narod SA (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the united states. JAMA 313(2):165–173CrossRefPubMed Iqbal J, Ginsburg O, Rochon P, Sun P, Narod SA (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the united states. JAMA 313(2):165–173CrossRefPubMed
14.
Zurück zum Zitat Gnerlich J, Deshpande A, Jeffe D, Sweet A, White N, Margenthaler J (2009) Elevated breast cancer mortality in young women (<40 years) compared with older women is attributed to poorer survival in early stage disease. J Am Coll Surg 208(3):341–347CrossRefPubMedPubMedCentral Gnerlich J, Deshpande A, Jeffe D, Sweet A, White N, Margenthaler J (2009) Elevated breast cancer mortality in young women (<40 years) compared with older women is attributed to poorer survival in early stage disease. J Am Coll Surg 208(3):341–347CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Leone BA, Romero A, Rabinovich MG et al (1988) Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis. The GOCS (Grupo Oncológico Cooperativo del Sur) experience. Am J Clin Oncol 11(6):618–622CrossRefPubMed Leone BA, Romero A, Rabinovich MG et al (1988) Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis. The GOCS (Grupo Oncológico Cooperativo del Sur) experience. Am J Clin Oncol 11(6):618–622CrossRefPubMed
16.
Zurück zum Zitat Tjokrowidjajal A, Lee CK, Houssami N, Lord S (2014) Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis. Intern Med J 44:764–770CrossRef Tjokrowidjajal A, Lee CK, Houssami N, Lord S (2014) Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis. Intern Med J 44:764–770CrossRef
17.
Zurück zum Zitat Baselga J, Cortes J, Kim SB et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366(2):109–119CrossRefPubMed Baselga J, Cortes J, Kim SB et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366(2):109–119CrossRefPubMed
18.
Zurück zum Zitat Dawood S, Broglio K, Buzdar A, Hortobagyi G, Giordano S (2009) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28(1):92–98CrossRefPubMedPubMedCentral Dawood S, Broglio K, Buzdar A, Hortobagyi G, Giordano S (2009) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28(1):92–98CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Satariano W, Ragland D (1994) The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120(2):104–110CrossRefPubMed Satariano W, Ragland D (1994) The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120(2):104–110CrossRefPubMed
21.
Zurück zum Zitat Cardoso F, Loibl S, Pagani O et al (2012) The European Society of breast cancer specialists recommendations for the management of young women with breast cancer. Eur J Cancer 48(18):3355–3377CrossRefPubMed Cardoso F, Loibl S, Pagani O et al (2012) The European Society of breast cancer specialists recommendations for the management of young women with breast cancer. Eur J Cancer 48(18):3355–3377CrossRefPubMed
22.
Zurück zum Zitat Gennari A, Stockler M, Puntoni M et al (2011) Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials. J Clin Oncol 29:2144–2149CrossRefPubMed Gennari A, Stockler M, Puntoni M et al (2011) Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials. J Clin Oncol 29:2144–2149CrossRefPubMed
23.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942CrossRef Early Breast Cancer Trialists’ Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942CrossRef
24.
Zurück zum Zitat Bleyer A, O’Leary M, Barr R, Ries L (2006) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975 to 2000. National Cancer Institute, NIH Publication, Bethesda (No. 06-5767) Bleyer A, O’Leary M, Barr R, Ries L (2006) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975 to 2000. National Cancer Institute, NIH Publication, Bethesda (No. 06-5767)
25.
Zurück zum Zitat Thomas A, Khan S, Chrischilles E, Schoreder M (2016) Initial surgery and survival in stage IV breast cancer in the United States, 1988–2011. JAMA Surg 151:424–431CrossRefPubMed Thomas A, Khan S, Chrischilles E, Schoreder M (2016) Initial surgery and survival in stage IV breast cancer in the United States, 1988–2011. JAMA Surg 151:424–431CrossRefPubMed
Metadaten
Titel
Ten-year survival in women with primary stage IV breast cancer
verfasst von
Lee Guek Eng
Shaheenah Dawood
Victoria Sopik
Benjamin Haaland
Pui San Tan
Nirmala Bhoo-Pathy
Ellen Warner
Javaid Iqbal
Steven A. Narod
Rebecca Dent
Publikationsdatum
14.09.2016
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2016
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3974-x

Weitere Artikel der Ausgabe 1/2016

Breast Cancer Research and Treatment 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.